课题基金 / 基金详情

Immunotherapeutic Targeting of the U1 snRNA Mutation in Cancer

Immunotherapeutic Targeting of the U1 snRNA Mutation in Cancer
癌症中 U1 snRNA 突变的免疫治疗靶向
批准号：
420493
负责人：
Stein Lincoln
金额：
$73.84万
依托单位：
Ontario Institute for Cancer Research (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
未结题
起止时间：
2020-03-01 至 2025-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=420493&lang=en
关键词：
Cancer Computational Biology Immunotherapy Non-Coding Rna Proteomics Targeted Cancer Therapy

项目摘要

项目成果

Stein Lincoln的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We seek funding to explore the development of novel therapeutics targeted against a novel class of driver mutation that we recently discovered in several types of hard-to-treat cancer. This mutation affects the U1 small nuclear RNA, a core component of th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying Cancer Tissue of Origin using Plasma Whole Genome Sequencing
Probing the developmental origins of pediatric cerebellar brain cancers using single cell profiling
EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.
The Cancer Genome Collaboratory
  • 批准号：
    308457
  • 项目类别：
    Operating Grants
  • 资助金额：
    $65.57万
  • 财政年份：
    2013
  • 负责人：
    Stein Lincoln
  • 依托单位：
    University of Toronto
海外基金